City

Portland (2)

Boston (1)

Duarte (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Alexey Danilov, MD (1)

City of Hope Medical Center (1)

Collaborator

Gilead Sciences (1)

National Cancer Institute (NCI) (1)

Oregon Health and Science University (1)

Intervention

duvelisib (1)

entospletinib (1)

laboratory biomarker analysis (1)

obinutuzumab (1)

pharmacological study (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

Refractory Small Lymphocytic Lymphoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Active, not recruiting

Recurrent Chronic Lymphocytic Leukemia
+3 more

Duvelisib

Duarte, California
+2 more

Oct 7, 2022

Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)

Completed

Anemia
+13 more

Entospletinib
+3 more

Portland, Oregon

OHSU Knight Cancer Institute

Apr 29, 2021